ZBTB7A基因敲除HEK293T细胞RIPA裂解液
收藏
产品编号 L11328
数量
¥ 1258.00
产品简介
使用说明
相关文件下载
相关产品
相关论文
产品问答

ZBTB7A Knockout HEK293T RIPA Lysate(ZBTB7A基因敲除HEK293T细胞RIPA裂解液)是通过同时表达Cas9、目的基因sgRNA和puromycin抗性基因并实现了目的基因CRISPR敲除的多克隆HEK293T细胞的RIPA裂解液。该细胞中目的基因的敲除已经通过T7EI法的验证。本产品可用于该目的基因敲除后其信号通路相关蛋白的研究,也可以用于该基因相应抗体的验证。

本RIPA裂解液源于可同时表达Cas9、目的基因sgRNA和puromycin抗性基因的慢病毒感染HEK293T细胞并经过puromycin筛选后获得的多克隆细胞。制备该细胞的相应慢病毒的基因序列的关键图谱信息请参考图1。

图1. 可同时表达sgRNA、Cas9和puromycin抗性的慢病毒其基因序列的关键图谱信息。

该细胞中目的基因的敲除已经通过T7EI法的验证。

由于本细胞是通过CRISPR/Cas9技术获得的多克隆细胞,基于CRISPR/Cas9技术的特点,理论上平均有2/3的细胞发生移码突变而导致了目的基因的敲除,平均有1/3的细胞并未发生移码突变。很多情况下有约2/3的细胞发生目的基因的敲除,已经足以进行很多的目的基因的生物学功能的研究了。如果希望获得100%基因敲除的细胞,可以自行使用本产品筛选单克隆细胞,或者委托碧云天进行单克隆细胞株的筛选服务。

本RIPA裂解液用于实验时,建议同时选购无任何靶向的对照细胞RIPA裂解液Control Knockout HEK293T RIPA Lysate (L00025)或靶向GFP的对照RIPA裂解液GFP Knockout HEK293T RIPA Lysate (L00027)

碧云天同时提供基于CRISPR/Cas9技术的ZBTB7A基因敲除的质粒(L11325 pLenti-ZBTB7A-sgRNA)慢病毒(L11326 ZBTB7A Knockout Lentivirus)HEK293T细胞(L11327 ZBTB7A Knockout HEK293T Cells)HEK293T敲除细胞的RIPA裂解液(L11328 ZBTB7A Knockout HEK293T RIPA Lysate)HEK293T敲除细胞的Trizol裂解液(L11329 ZBTB7A Knockout HEK293T Trizol Lysate)等产品,具体请在碧云天网站查询或在本产品网页点击相应产品。

用于制备本产品的RIPA裂解液为碧云天生产的P0013B RIPA裂解液(强),其具体组分请查阅产品网页或说明书。

ZBTB7A基因的基本信息如下:

Species Gene Symbol Gene ID GenBank Accession Transcript
Human ZBTB7A 51341 BC113511 NM_015898

 

About the gene
Official Symbol ZBTB7A
Previous Symbol ZBTB7
Official Full Name zinc finger and BTB domain containing 7A
Synonyms FBI-1; LRF; DKFZp547O146; pokemon; ZNF857A
Location 19p13.3
Gene Type protein-coding gene
Uniprot ID O95365
Pathway/Library Ubiquitin Ligases Genes Library
Gene Summary Transcription factor that represses the transcription of a wide range of genes involved in cell proliferation and differentiation (PubMed:14701838, PubMed:17595526, PubMed:20812024, PubMed:25514493, PubMed:26455326, PubMed:26816381). Directly and specifically binds to the consensus sequence 5'-GACCCCCCCCC-3' and represses transcription both by regulating the organization of chromatin and through the direct recruitment of transcription factors to gene regulatory regions (PubMed:12004059, PubMed:17595526, PubMed:20812024, PubMed:25514493, PubMed:26816381). Negatively regulates SMAD4 transcriptional activity in the TGF-beta signaling pathway through these two mechanisms (PubMed:25514493). That is, recruits the chromatin regulator HDAC1 to the SMAD4-DNA complex and in parallel prevents the recruitment of the transcriptional activators CREBBP and EP300 (PubMed:25514493). Collaborates with transcription factors like RELA to modify the accessibility of gene transcription regulatory regions to secondary transcription factors (By similarity). Also directly interacts with transcription factors like SP1 to prevent their binding to DNA (PubMed:12004059). Functions as an androgen receptor/AR transcriptional corepressor by recruiting NCOR1 and NCOR2 to the androgen response elements/ARE on target genes (PubMed:20812024). Thereby, negatively regulates androgen receptor signaling and androgen-induced cell proliferation (PubMed:20812024). Involved in the switch between fetal and adult globin expression during erythroid cells maturation (PubMed:26816381). Through its interaction with the NuRD complex regulates chromatin at the fetal globin genes to repress their transcription (PubMed:26816381). Specifically represses the transcription of the tumor suppressor ARF isoform from the CDKN2A gene (By similarity). Efficiently abrogates E2F1-dependent CDKN2A transactivation (By similarity). Regulates chondrogenesis through the transcriptional repression of specific genes via a mechanism that also requires histone deacetylation (By similarity). Regulates cell proliferation through the transcriptional regulation of genes involved in glycolysis (PubMed:26455326). Involved in adipogenesis through the regulation of genes involved in adipocyte differentiation (PubMed:14701838). Plays a key role in the differentiation of lymphoid progenitors into B and T lineages (By similarity). Promotes differentiation towards the B lineage by inhibiting the T-cell instructive Notch signaling pathway through the specific transcriptional repression of Notch downstream target genes (By similarity). Also regulates osteoclast differentiation (By similarity). May also play a role, independently of its transcriptional activity, in double-strand break repair via classical non-homologous end joining/cNHEJ (By similarity). Recruited to double-strand break sites on damage DNA, interacts with the DNA-dependent protein kinase complex and directly regulates its stability and activity in DNA repair (By similarity). May also modulate the splicing activity of KHDRBS1 toward BCL2L1 in a mechanism which is histone deacetylase-dependent and thereby negatively regulates the pro-apoptotic effect of KHDRBS1 (PubMed:24514149). ZBT7A_HUMAN,O95365
包装清单:
产品编号 产品名称 包装
L11328 ZBTB7A Knockout HEK293T RIPA Lysate 100µg
说明书 1份
保存条件:

-20℃保存,3个月有效;-80℃保存,至少一年有效。

注意事项:

碧云天拥有sgRNA序列的知识产权,如果需要sgRNA序列,请在订购后发送邮件向info@beyotime.com索取。sgRNA序列信息与本产品,未经碧云天书面许可不得用于任何商业用途,也不得移交给订货人所在实验室外的任何个人或单位。使用者在发表研究论文或结果时,应注明来源。

对于非目录产品的CRISPR基因敲除细胞RIPA裂解液的定制,可联系碧云天技术服务service@beyotime.com

本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。

为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用说明:
1. 细胞RIPA裂解液样品的蛋白浓度测定:
推荐使用碧云天生产的BCA蛋白浓度测定试剂盒(P0009/P0010/P0010S/P0011/P0012/P0012S)测定蛋白浓度。由于本产品含有较高浓度的去垢剂,不建议使用Bradford法测定本产品的蛋白浓度。RIPA裂解液的使用说明请参考:https://www.beyotime.com/product/P0013B.htm
2. 细胞RIPA裂解液的使用:
本RIPA裂解液测定浓度后加入SDS-PAGE蛋白上样缓冲液即可用于SDS-PAGE、Western检测、以及目的基因抗体的验证等。
相关产品:
产品编号 产品名称 包装
L00025 Control Knockout HEK293T RIPA Lysate 100µg
L00027 GFP Knockout HEK293T RIPA Lysate 100µg
P0009 BCA蛋白浓度测定试剂盒(增强型) 5000次
P0010 BCA蛋白浓度测定试剂盒(增强型) 500次
P0010S BCA蛋白浓度测定试剂盒(增强型) 200次
P0011 BCA蛋白浓度测定试剂盒 5000次
P0012 BCA蛋白浓度测定试剂盒 500次
P0012S BCA蛋白浓度测定试剂盒 200次
P0012A SDS-PAGE凝胶配制试剂盒 可制30-50块胶
P0012AC SDS-PAGE凝胶快速配制试剂盒 可制30-50块胶
P0013B RIPA裂解液(强) 100ml
P0014A/B SDS-PAGE电泳液(Tris-Gly, Powder) 1/10L
P0014C/D SDS-PAGE电泳液(Tris-Gly, 10X) 100/500ml
P0015 SDS-PAGE蛋白上样缓冲液(5X) 2ml
P0015L SDS-PAGE蛋白上样缓冲液(5X) 15ml
P0015B SDS-PAGE蛋白上样缓冲液(2X) 5ml
P0015F SDS-PAGE蛋白上样缓冲液(6X) 2ml
相关产品请点击如下按钮:
使用本产品的文献: